General Information
Revision date
2018-05-25
Product name
Cinnarizine
CAS No.
298-57-7
1.2.1 Relevant identified uses
Reference material for laboratory use only
1.2.2. Uses advised against
No further relevant information available
Emergency telephone
+44 (0) 20 3080 6561 (Monday - Friday 8am - 5pm
Icons in SDS
Company Information
company name
British Pharmacopoeia Commission
e-mail address of the competent person responsible for the Safety Data Sheet
bpcrs@mhra.gov.uk
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H336
Hazard statements
Code
Statements
H336
May cause drowsiness or dizziness
Section 2
CLP CLASSIFICATION
GHS07 STOT SE 3 H336 May cause drowsiness or dizziness.
2.2 Label elements
Labelling according to Regulation (EC) No 1272/2008 The substance is classified and labelled according to the CLP regulation.
Hazard pictograms
GHS07
Hazard statements
H336 May cause drowsiness or dizziness.
Precautionary statements
P261 Avoid breathing dust/fume/gas/mist/vapours/spray. P304+P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing. P312 Call a POISON CENTER/doctor if you feel unwell. P403+P233 Store in a well-ventilated place. Keep container tightly closed. P405 Store locked up. P501 Dispose of contents/container in accordance with local/regional/national/international regulations.
PBT Substances
Not applicable
vPvB Substances
Not applicable
